U.S. federal trademark · Serial No. 79216266 · Reg. No. 5377511
Pharmaceutical preparations for treatment of autoimmune diseases; pharmaceutical preparations for treatment of inflammatory diseases; pharmaceutical preparations for treatment of cancer; pharmaceutical preparations for treatment of rheumatoid arthritis, juvenile idiopathic arthritis, axial spondyloarthritis, psoriatic arthritis, Crohn's disease, paediatric Crohn's disease, ulcerative colitis, psoriasis, paediatric plaque psoriasis, uveitis, hidradenitis suppurativa, asthma, bronchitis, CODP, bronchial asthma, allergic rhinitis, allergic airway inflammation, allergic arthritis, Non-Hodgkins lymphoma (NHL), chronic lymphocytic leukaemia (CLL), granulomatosis with polyangiitis, and microscopic polyangiitis; pharmaceutical preparations for prevention of autoimmune diseases; pharmaceutical preparations for prevention of inflammatory diseases; pharmaceutical preparations for prevention of cancer; pharmaceutical preparations for prevention of rheumatoid arthritis, juvenile idiopathic arthritis, axial spondyloarthritis, psoriatic arthritis, Crohn's disease, paediatric Crohn's disease, ulcerative colitis, psoriasis, paediatric plaque psoriasis, uveitis, hidradenitis suppurativa, asthma, bronchitis, CODP, bronchial asthma, allergic rhinitis, allergic airway inflammation, allergic arthritis, Non-Hodgkins lymphoma (NHL), chronic lymphocytic leukaemia (CLL), granulomatosis with polyangiitis, and microscopic polyangiitis
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.